Julia Garcia-Fuster
banner
garciafusterlab.bsky.social
Julia Garcia-Fuster
@garciafusterlab.bsky.social
Full Professor, Pharmacology, @FMedicinaUIB
PI, Neuropharmacology Research Group, @uib.cat
Director, @iunics-uib.bsky.social, Scientfic Subdirector, @idisba.bsky.social
New PhD alert! Congratulations to Carles Colom-Rocha for his PhD defense and outstanding performance. And many thanks to the Committee Members that joined us yesterday to evaluate it. Enjoy your title Dr. Colom-Rocha. @iunics-uib.bsky.social @uib.cat @idisba.bsky.social
December 19, 2025 at 7:11 AM
Reposted by Julia Garcia-Fuster
Nou article a #Docusalut: Neurotoxic biomarkers of ethanol exposure: from adolescent vulnerability to adult voluntary intake in rats of both sexes http://hdl.handle.net/20.500.13003/25904 @idisba.bsky.social @garciafusterlab.bsky.social  #PublicaSalutIB
December 10, 2025 at 6:30 PM
Take a look at our short story characterizing the preclinical antidepressant-like response of a novel imidazoline-2 receptor compound synthesized by Carmen Escolano Lab link.springer.com/article/10.1...
Sex differences in the antidepressant-like response induced by the imidazoline-2 receptor compound 12d, a (3-phenylcarbamoyl-3,4-dihydro‑2H‑pyrrol-2-yl)phosphonate - Pharmacological Reports
Background The synthesis of (3-phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonates provided novel compounds with relevant affinities for imidazoline 2 (I2) receptors in human brain tissues. A sele...
link.springer.com
December 11, 2025 at 10:13 AM
Check out our latest publication characterizing psilocybin as a novel antidepressant for adolescent rats of both sexes authors.elsevier.com/sd/article/S...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
authors.elsevier.com
October 31, 2025 at 10:23 AM
Enhorabuena a los miembros predoc de nuestro grupo por presentar 2 propuestas excelentes y ganar 1 de los premios. Muchas gracias #UIBEmprèn por esta iniciativa.
🏆 Premi #UIBEmprèn a la Millor Idea Emprenedora #IUNICS 2025!

👏 Joves investigadors han presentat solucions innovadores fruit de la #recerca impulsada per l'Institut Universitari d'Investigació en Ciències de la Salut.

@fueib.bsky.social @iunics-uib.bsky.social

diari.uib.cat/Hemeroteca/E...
March 28, 2025 at 5:27 AM
Reposted by Julia Garcia-Fuster
March 20, 2025 at 10:10 AM
Reposted by Julia Garcia-Fuster
March 20, 2025 at 5:01 PM
Here is the link to "Characterizing the therapeutical use of ketamine for adolescent rats of both sexes: Antidepressant-like efficacy and safety profile": our latest publication with @jordijornet.bsky.social as first author: www.sciencedirect.com/science/arti...
Characterizing the therapeutical use of ketamine for adolescent rats of both sexes: Antidepressant-like efficacy and safety profile
While ketamine was approved for treatment-resistant depression in adult patients, its efficacy and safety profile for adolescence still requires furth…
www.sciencedirect.com
December 25, 2024 at 5:24 AM
Celebrating a year full of accomplishments with these great bunch of people. Happy holidays 🙂
December 22, 2024 at 5:13 AM
Reposted by Julia Garcia-Fuster
Three must read papers for PhD students. #scisky #PhD #science #research #academicsky

1. The importance of stupidity in scientific research

Open Access
journals.biologists.com/jcs/article/...
November 24, 2024 at 1:54 PM
Reposted by Julia Garcia-Fuster
There are already many articles for which there is more attention on Bluesky than on other comparable micro-blogging sites, meaning the academic community and the general public have clearly adopted Bluesky as one of its core places to disseminate and discuss new research.

A Place of Joy.
December 3, 2024 at 2:00 PM
Reposted by Julia Garcia-Fuster
We have updated and expanded our database of fellowships for POSTDOCS in neuroscience/neurology/cog science.

For each fellowship, we provide a description, $ amount, deadline, link, and eligibility criteria.

Download our database freely here: research.jhu.edu/rdt/funding-... pic.x.com/eEhXhlOzEj
November 24, 2024 at 10:35 PM
Reposted by Julia Garcia-Fuster
Safety concerns following the use of ketamine as a potential antidepressant for adolescent rats of both sexes https://www.biorxiv.org/content/10.1101/2024.11.08.622617v1
Safety concerns following the use of ketamine as a potential antidepressant for adolescent rats of both sexes https://www.biorxiv.org/content/10.1101/2024.11.08.622617v1
While ketamine is already approved for treatment resistant depression in adult patients, its efficac
www.biorxiv.org
November 11, 2024 at 6:01 PM